HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text All Versions of this Article: 2333031617v1 233/3/682    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Awai, K. Articles by Yamashita, Y. Search for Related Content PubMed PubMed Citation Articles by Awai, K. Articles by Yamashita, Y.

Moderate versus High Concentration of Contrast Material for Aortic and Hepatic Enhancement and Tumor-to-Liver Contrast at Multi–Detector Row CT¹

¹ From the Department of Radiology, Kinki University School of Medicine, 2–23 Ono-higashi, Osaka-Sayama, Osaka 589-8511, Japan (K.A., M.I., Y. Yagyu, M.W., T.S., S.N., R.K., Y.N.); and Department of Radiology, Kumamoto University Graduate School of Medical Science, Kumamoto, Japan (Y. Yamashita). Received October 10, 2003; revision requested December 30; revision received February 12, 2004; accepted March 26. Address correspondence to K.A.

PURPOSE: To prospectively evaluate aortic and hepatic enhancement and depiction of hypervascular hepatocellular carcinoma (HCC) between two contrast materials with moderate and high iodine concentrations when administered at same iodine dose and injection duration at multi–detector row helical computed tomography (CT).

MATERIALS AND METHODS: Institutional review board approval and informed patient consent were obtained. One hundred eighty-six patients were studied, and 67 patients with hypervascular HCC were identified. Ninety-four patients were assigned to receive iohexol 350 (mg iodine per milliliter) with protocol A; 92, iohexol 300 with protocol B. In both protocols, iohexol with same iodine load per weight (518 mg/kg) was administered with same injection duration (25 seconds). Multiphase CT scanning was started 10, 20, 50, and 180 seconds after the trigger (threshold level set at increase of 100 HU over baseline CT number of aorta). Enhancement of aorta and liver was measured in 186 patients. Tumor-to-liver contrast was measured in 67 patients with hypervascular HCC. Statistical analysis was performed with Mann-Whitney U test.

RESULTS: Medians of aortic enhancement during four phases were 325, 185, 112, and 69 HU with protocol A. Corresponding values were 344, 266, 121, and 73 HU with protocol B. During all phases, aortic enhancement was significantly higher with protocol B (P = .046, P < .001, P < .001, and P = .002). Hepatic enhancement during four phases was 6, 21, 48, and 34 HU with protocol A. Corresponding values were 3, 17, 47, and 35 HU with protocol B. Hepatic enhancement was significantly higher with protocol A during first and second phases (P < .001 for both), although there was no significant difference between protocols during third and fourth phases (P = .778 and P = .178, respectively). Medians of tumor-to-liver contrast during four phases were 22, 34, 0.5, and –1.1 HU with protocol A. Corresponding values were 23, 45, 0, and –8.6 HU with protocol B. Tumor-to-liver contrast was significantly higher with protocol B during second phase (P = .049), although there was no difference between protocols during other phases.

CONCLUSION: When total iodine dose was adjusted to body weight and injection duration was fixed, rapid administration of moderate concentration of contrast material was more effective for depiction of hypervascular HCC than was high concentration of contrast material.

© RSNA, 2004

Index terms: Aorta, CT, 56.12112, 56.12114, 56.12115 • Computed tomography (CT), contrast media • Liver, CT, 761.12112, 761.12114, 761.12115 • Liver, diseases, 761.323 • Liver neoplasms, CT, 761.12112, 761.12114, 761.12115

This article has been cited by other articles:

				X. Ma, A. E. Samir, N.-S. Holalkere, and D. V. Sahani Optimal Arterial Phase Imaging for Detection of Hypervascular Hepatocellular Carcinoma Determined by Continuous Image Capture on 16-MDCT Am. J. Roentgenol., September 1, 2008; 191(3): 772 - 777. [Abstract] [Full Text] [PDF]

				X. Fei, X. Du, Q. Yang, Y. Shen, P. Li, J. Liao, and K. Li 64-MDCT Coronary Angiography: Phantom Study of Effects of Vascular Attenuation on Detection of Coronary Stenosis Am. J. Roentgenol., July 1, 2008; 191(1): 43 - 49. [Abstract] [Full Text] [PDF]

				F. F. Behrendt, A. H. Mahnken, S. Stanzel, P. Seidensticker, E. Jost, R. W. Gunther, and G. Muhlenbruch Intraindividual Comparison of Contrast Media Concentrations for Combined Abdominal and Thoracic MDCT Am. J. Roentgenol., July 1, 2008; 191(1): 145 - 150. [Abstract] [Full Text] [PDF]

				Y. Yanaga, K. Awai, T. Nakaura, T. Namimoto, S. Oda, Y. Funama, and Y. Yamashita Optimal Contrast Dose for Depiction of Hypervascular Hepatocellular Carcinoma at Dynamic CT Using 64-MDCT Am. J. Roentgenol., April 1, 2008; 190(4): 1003 - 1009. [Abstract] [Full Text] [PDF]

				S. T. Schindera, R. C. Nelson, S. Mukundan Jr, E. K. Paulson, T. A. Jaffe, C. M. Miller, D. M. DeLong, K. Kawaji, T. T. Yoshizumi, and E. Samei Hypervascular Liver Tumors: Low Tube Voltage, High Tube Current Multi Detector Row CT for Enhanced Detection Phantom Study Radiology, December 1, 2007; 246(1): 125 - 132. [Abstract] [Full Text] [PDF]

				H.M. Silvennoinen, L.M. Hamberg, L. Valanne, and G.J. Hunter Increasing Contrast Agent Concentration Improves Enhancement in First-Pass CT Perfusion AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1299 - 1303. [Abstract] [Full Text] [PDF]

				F. Cademartiri, N. R. Mollet, P. A. Lemos, F. Saia, M. Midiri, P. J. de Feyter, and G. P. Krestin Higher Intracoronary Attenuation Improves Diagnostic Accuracy in MDCT Coronary Angiography Am. J. Roentgenol., October 1, 2006; 187(4): W430 - W433. [Abstract] [Full Text] [PDF]

				S. Kubo, E. Tadamura, M. Yamamuro, R. Hosokawa, T. Kimura, T. Kita, M. Komeda, and K. Togashi Thoracoabdominal-aortoiliac MDCT angiography using reduced dose of contrast material. Am. J. Roentgenol., August 1, 2006; 187(2): 548 - 554. [Abstract] [Full Text] [PDF]

				W. Schima, R. Hammerstingl, C. Catalano, L. Marti-Bonmati, E. J. Rummeny, F. T. Montero, A. Dirisamer, B. Westermayer, M. Bellomi, D. Brisbois, et al. Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate. Am. J. Roentgenol., June 1, 2006; 186(6): 1571 - 1579. [Abstract] [Full Text] [PDF]

				P. T. Johnson and E. K. Fishman IV Contrast Selection for MDCT: Current Thoughts and Practice Am. J. Roentgenol., February 1, 2006; 186(2): 406 - 415. [Abstract] [Full Text] [PDF]

				K. T. Bae, K. Awai, and Y. Yamashita Comparison of Moderate versus High Concentration of Contrast Media Injected at the Same Total Iodine Dose and Fixed Injection Duration * Drs Awai and Yamashita respond: Radiology, August 1, 2005; 236(2): 740 - 741. [Full Text] [PDF]